Gene Therapy for Ovarian Cancer - A Pipeline Analysis Report
- Published: Feb 2018
- Pages: 73
- SKU: IRTNTR20288
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
This pipeline analysis report provides detailed insights into the clinical trials landscape of the gene therapy for ovarian cancer including molecules at various development stages. The report also offers in-depth information about the therapeutic assessment of the pipeline molecules based on various segmentations such as route of administration and target.
Gene therapy for ovarian cancer industry insights
Technavio’s market research analysts have predicted that with the emergence of gene therapy as an approach for the treatment of ovarian cancer, the global ovarian cancer market will witness considerable growth in the coming years. With the potential to cure ovarian cancer by replacing faulty genes with normal ones, replacement gene therapy will gain prominence during the next few years.
According to gene therapy for ovarian cancer industry analysis, companies are focusing on evaluating pipeline molecules for recurrent ovarian epithelial cancer and platinum-resistant ovarian cancer. Our market research analysts have also identified that most of the gene therapy candidates in the pipeline are being developed for platinum-resistant ovarian cancer.
Gene therapy industry report: Companies covered
This pipeline analysis report provides a comprehensive analysis of the companies that are involved in the development of gene therapy molecules for the treatment of ovarian cancer. The report provides detailed information on the various stages of molecules developed by companies for different indications. Furthermore, this pipeline analysis report also provides information about the gene therapy molecules discontinued by companies.
Some of the companies covered in this pipeline analysis report are
- Takara Bio
- VBL Therapeutics
- CELSION
- Targovax
Therapeutic assessment of the gene therapy for ovarian cancer by route of administration
- Intravenous
- Intratumoral
- Intraperitoneal
The walls of abdominal organs such as the stomach and intestines and the abdominal (peritoneal) cavity are lined with a thin and transparent membrane called peritoneum. According to our research experts, the majority of gene therapy molecules currently in the pipeline for ovarian cancer are developed for the intraperitoneal route of administration, in which, the drug is administered directly into the peritoneum.
Therapeutic assessment of the gene therapy for ovarian cancer by target
- NY-ESO-1
- p53 gene
- IL – 12
- Thymidine Kinase
According to this pipeline analysis report, the current pipeline molecules for ovarian cancer gene therapy are mainly evaluated by NY-ESO-1 target therapeutic assessment. However, several companies have not disclosed the target for most of the molecules in the early development stages.
Want a bigger picture? Try a FREE sample of this report now!
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Key questions answered in the report include
- What are the gene therapy molecules in the various development stages of ovarian cancer?
- What are the companies that are currently involved in the development of gene therapy molecules for ovarian cancer?
- Insight into discontinued/inactive molecules with appropriate reasoning?
- What are the major regulatory authorities approving drugs in various regions?
- Detailed profiling of each active molecule.
Technavio also offers customization on reports based on specific client requirement.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
PART 05: MAJOR REGULATORY AUTHORITIES
- US
- Europe
- China
PART 06: PIPELINE LANDSCAPE
PART 07: COMPARATIVE ANALYSIS
- Discovery stage molecules
- Pre-clinical stage molecules
- Inactive and discontinued molecules
PART 08: INDICATION ANALYSIS
PART 09: THERAPEUTIC ASSESSMENT (THERAPY BASED)
PART 10: THERAPEUTIC ASSESSMENT (ROA BASED)
PART 11: THERAPEUTIC ASSESSMENT BY TARGET
PART 12: KEY COMPANIES
- Active companies: Category and parameters
PART 13: APPENDIX
- List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
